GD2 antibodies are used to treat high-risk neuroblastoma. They work by attaching to the GD2 protein on cancer cells, which helps the immune system recognize and destroy them.
DINUTUXIMAB treats neuroblastoma, a cancer that occurs in nerve cells. It works by slowing down the growth of cancer cells. It is a monoclonal antibody.
Disclaimer: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.
Subscribe and save
Get prescription saving tips and more from GoodRx Health. Enter your email to sign up